Ulla Ribel

5.4k total citations · 2 hit papers
44 papers, 4.3k citations indexed

About

Ulla Ribel is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Ulla Ribel has authored 44 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 21 papers in Endocrinology, Diabetes and Metabolism and 20 papers in Surgery. Recurrent topics in Ulla Ribel's work include Pancreatic function and diabetes (20 papers), Diabetes Management and Research (13 papers) and Diabetes Treatment and Management (10 papers). Ulla Ribel is often cited by papers focused on Pancreatic function and diabetes (20 papers), Diabetes Management and Research (13 papers) and Diabetes Treatment and Management (10 papers). Ulla Ribel collaborates with scholars based in Denmark, United States and United Kingdom. Ulla Ribel's co-authors include Svend Havelund, Inge Jonassen, Jan Markussen, Peter Kurtzhals, Philip J. Larsen, Peter Lommer Kristensen, Per Bo Jensen, Niels Vrang, Birgitte S. Wulff and Martin E. Judge and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Ulla Ribel

43 papers receiving 4.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hypothalamic CART is a new anorectic peptide regulated by leptin

1998 1.0k citations Ulla Ribel et al. Nature profile →
Monomeric insulins obtained by protein engineering and their medical implications

1988 397 citations Jens Brange, Ulla Ribel et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ulla Ribel Denmark	27	1.9k	1.6k	1.5k	991	676	44	4.3k
Walter G. Thomas Australia	44	1.4k 0.7×	3.8k 2.4×	949 0.6×	281 0.3×	997 1.5×	145	7.4k
Nabil A. Elshourbagy United States	40	873 0.5×	2.8k 1.8×	1.1k 0.8×	373 0.4×	1.1k 1.7×	74	5.6k
Lauge Schäffer Denmark	24	1.4k 0.8×	1.8k 1.2×	827 0.6×	387 0.4×	416 0.6×	29	3.1k
Qingling Huang China	35	717 0.4×	2.7k 1.7×	437 0.3×	651 0.7×	1.1k 1.6×	75	4.4k
Pierre Carayon France	34	1.6k 0.8×	1.3k 0.8×	503 0.3×	314 0.3×	554 0.8×	98	5.0k
Tommie W. Redding United States	40	1.8k 1.0×	1.6k 1.0×	368 0.3×	521 0.5×	348 0.5×	128	5.5k
Howard S. Tager United States	43	1.7k 0.9×	3.1k 2.0×	1.8k 1.3×	221 0.2×	417 0.6×	110	5.7k
Margaret A. Cascieri United States	47	1.5k 0.8×	4.0k 2.6×	769 0.5×	275 0.3×	904 1.3×	139	6.7k
Birgitte Holst Denmark	45	904 0.5×	3.2k 2.0×	842 0.6×	2.5k 2.6×	1.7k 2.5×	124	6.5k
Neil J. Fraser United Kingdom	19	495 0.3×	2.8k 1.8×	585 0.4×	436 0.4×	526 0.8×	26	4.8k

Countries citing papers authored by Ulla Ribel

Since Specialization

Citations

This map shows the geographic impact of Ulla Ribel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulla Ribel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulla Ribel more than expected).

Fields of papers citing papers by Ulla Ribel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ulla Ribel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulla Ribel. The network helps show where Ulla Ribel may publish in the future.

Co-authorship network of co-authors of Ulla Ribel

This figure shows the co-authorship network connecting the top 25 collaborators of Ulla Ribel. A scholar is included among the top collaborators of Ulla Ribel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ulla Ribel. Ulla Ribel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kildegaard, Jonas, Stephen T. Buckley, Rasmus Hjorth Nielsen, et al.. (2019). Elucidating the Mechanism of Absorption of Fast-Acting Insulin Aspart: The Role of Niacinamide. Pharmaceutical Research. 36(3). 49–49. 63 indexed citations

Havelund, Svend, Ulla Ribel, František Hubálek, et al.. (2015). Investigation of the Physico-Chemical Properties that Enable Co-Formulation of Basal Insulin Degludec with Fast-Acting Insulin Aspart. Pharmaceutical Research. 32(7). 2250–2258. 39 indexed citations

Norrman, Mathias, Ulla Ribel, Kasper Huus, et al.. (2012). Insulin analog with additional disulfide bond has increased stability and preserved activity. Protein Science. 22(3). 296–305. 64 indexed citations

Nielsen, F. S., et al.. (2012). Comparison of the pharmacokinetics of three concentrations of insulin aspart during continuous subcutaneous insulin infusion (CSII) in a pig model. Journal of Pharmacy and Pharmacology. 65(2). 230–235. 4 indexed citations

Ribel, Ulla, et al.. (2011). Identification of Anchor Points for Chemical Modification of a Small Cysteine‐Rich Protein by Using a Cysteine Scan. ChemBioChem. 12(16). 2448–2455. 7 indexed citations

Andersen, Asser S., Eva Palmqvist, Allan C. Shaw, et al.. (2010). Backbone cyclic insulin. Journal of Peptide Science. 16(9). 473–479. 12 indexed citations

Sajid, Waseem, Nikolaj Kulahin, Gerd Schluckebier, et al.. (2010). Structural and Biological Properties of the Drosophila Insulin-like Peptide 5 Show Evolutionary Conservation. Journal of Biological Chemistry. 286(1). 661–673. 51 indexed citations

Fledelius, Christian, et al.. (2008). Insulin Detemir Decreases Gain in Body Weight and Fat Mass in ZDF Rats when Compared with both NPH and Insulin Glargine. Canadian Journal of Diabetes. 32(4). 334–334. 1 indexed citations

Schäffer, Lauge, Christian L. Brand, Ulla Ribel, et al.. (2008). A novel high-affinity peptide antagonist to the insulin receptor. Biochemical and Biophysical Research Communications. 376(2). 380–383. 130 indexed citations

10.

Jonassen, Inge, Svend Havelund, Ulla Ribel, et al.. (2005). Biochemical and Physiological Properties of a Novel Series of Long-Acting Insulin Analogs Obtained by Acylation with Cholic Acid Derivatives. Pharmaceutical Research. 23(1). 49–55. 42 indexed citations

11.

Larsen, Marianne O., Claus Bogh Juhl, Niels Pörksen, et al.. (2004). β-Cell function and islet morphology in normal, obese, and obese β-cell mass-reduced Göttingen minipigs. American Journal of Physiology-Endocrinology and Metabolism. 288(2). E412–E421. 30 indexed citations

12.

Havelund, Svend, Ulla Ribel, Inge Jonassen, et al.. (2004). The Mechanism of Protraction of Insulin Detemir, a Long-Acting, Acylated Analog of Human Insulin. Pharmaceutical Research. 21(8). 1498–1504. 336 indexed citations

13.

Sturis, Jeppe, C. F. Gotfredsen, John Rømer, et al.. (2003). GLP‐1 derivative liraglutide in rats with β‐cell deficiencies: influence of metabolic state on β‐cell mass dynamics. British Journal of Pharmacology. 140(1). 123–132. 176 indexed citations

14.

Kurtzhals, Peter, Svend Havelund, Inge Jonassen, et al.. (1996). Albumin Binding and Time Action of Acylated Insulins in Various Species. Journal of Pharmaceutical Sciences. 85(3). 304–308. 66 indexed citations

15.

Ribel, Ulla, et al.. (1992). Application of the euglycaemic clamp technique to bioassay of insulin analogues. Biologicals. 20(2). 135–142. 2 indexed citations

16.

Vølund, Aa., Jens Brange, Kirsten Drejer, et al.. (1991). In Vitro and In Vivo Potency of Insulin Analogues Designed for Clinical Use. Diabetic Medicine. 8(9). 839–847. 60 indexed citations

17.

Brange, Jens, Ulla Ribel, J. F. Hansen, et al.. (1988). Monomeric insulins obtained by protein engineering and their medical implications. Nature. 333(6174). 679–682. 397 indexed citations breakdown →

18.

Markussen, Jan, Mogens Trier Hansen, Philip Hougaard, et al.. (1987). Soluble, prolonged-acting insulin derivatives. II. Degree of protraction and crystallizability of insulins substituted in positions A17, B8, B13, B27 and B30. Protein Engineering Design and Selection. 1(3). 215–223. 51 indexed citations

19.

Ribel, Ulla, et al.. (1981). Pharmacokinetics of Theophylline and 3‐Methylxanthine in Guinea Pigs. II. Multiple Dose Administration. Acta Pharmacologica et Toxicologica. 48(1). 8–12. 1 indexed citations

20.

Ribel, Ulla, et al.. (1981). Pharmacokinetics of Theophylline and 3‐Methylxanthine in Guinea Pigs. I. Single Dose Administration. Acta Pharmacologica et Toxicologica. 48(1). 1–7. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact